Buy OvaScience Stock | OVAS Stock Price & Latest News | Public
OVAS

OvaScience

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About OVAS

    Millendo Therapeutics, Inc. engages in the development of treatments for orphan endocrine diseases. Its product pipeline includes Livoletide (AZP-531) for the treatment of Prader-Willi syndrome; Nevanimibe for classic congenital adrenal hyperplasia; and Neurokinin 3 rec...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$35,71M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$9.88
    1 Year Low$1.26
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app